Two cases of liver cirrhosis treated with lusutrombopag before partial splenic embolization

Lusutrombopag, a small molecule thrombopoietin receptor agonist, has been approved for the treatment of chronic liver disease-associated thrombocytopenia due to hypersplenism in patients scheduled to undergo elective invasive procedures in Japan. We performed partial splenic embolization (PSE) after...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Fukushima J Med Sci
Hlavní autoři: Fujita, Masashi, Abe, Kazumichi, Hayashi, Manabu, Okai, Ken, Takahashi, Atsushi, Ohira, Hiromasa
Médium: Artigo
Jazyk:Inglês
Vydáno: The Fukushima Society of Medical Science 2017
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792501/
https://ncbi.nlm.nih.gov/pubmed/29142151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5387/fms.2017-07
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky